title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,BGNE,0.026343,Neutral,0.037824
"SAP's Q2 Earnings Decline Y/Y, Revenues Up on Cloud Strength",20220721T153900,https://www.zacks.com/stock/news/1955922/saps-q2-earnings-decline-yy-revenues-up-on-cloud-strength,BGNE,0.032078,Neutral,0.111421
Stocks That Hit 52-Week Lows On Tuesday,20220524T161351,https://www.benzinga.com/markets/options/22/05/27375519/52-weeks-high-and-low-article,BGNE,0.010175,Neutral,0.003559
"Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket - Akanda  ( NASDAQ:AKAN ) , Aspen Aerogels  ( NYSE:ASPN ) ",20221130T124216,https://www.benzinga.com/news/22/11/29903371/why-horizon-therapeutics-shares-are-trading-higher-by-over-30-here-are-32-stocks-moving-premarket,BGNE,0.110462,Neutral,0.0
"Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session - Beauty Health  ( NASDAQ:SKIN ) ",20240313T101613,https://www.benzinga.com/news/24/03/37649482/beauty-health-posts-upbeat-sales-joins-siga-technologies-maxcyte-and-other-big-stocks-moving-higher,BGNE,0.24289,Somewhat-Bullish,0.346732
Stocks That Hit 52-Week Lows On Thursday,20220310T165722,https://www.benzinga.com/news/22/03/26083670/stocks-that-hit-52-week-lows-on-thursday,BGNE,0.014015,Neutral,-0.007427
Mirati Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates,20230228T210100,https://www.prnewswire.com/news-releases/mirati-therapeutics-reports-fourth-quarter-and-full-year-2022-financial-results-and-recent-corporate-updates-301758465.html,BGNE,0.042953,Neutral,0.022323
"Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket - Bone Biologics  ( NASDAQ:BBLG ) , Applied UV  ( NASDAQ:AUVI ) ",20230615T120517,https://www.benzinga.com/news/23/06/32871563/why-microvision-shares-are-trading-higher-by-28-here-are-20-stocks-moving-premarket,BGNE,0.222157,Neutral,-0.029557
99 Biggest Movers From Yesterday,20220512T082956,https://www.benzinga.com/news/22/05/27156577/99-biggest-movers-from-yesterday,BGNE,0.063655,Neutral,-0.017103
Novartis  ( NVS )  Anti-PD-1 Drug Validated by EMA for Lung Cancer,20220407T160500,https://www.zacks.com/stock/news/1894957/novartis-nvs-anti-pd-1-drug-validated-by-ema-for-lung-cancer,BGNE,0.245278,Neutral,0.023742
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20230703T210100,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,BGNE,0.040795,Neutral,0.032589
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",20230925T210100,https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,BGNE,0.018757,Neutral,0.026387
"Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte",20230918T210100,https://www.prnewswire.com/news-releases/head-and-neck-squamous-cell-carcinoma-market-to-witness-upsurge-in-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---pfizer-merck-eisai-astrazeneca-innate-roche-glaxosmithkline-beigene-io-biotech-incyt-301930322.html,BGNE,0.069361,Neutral,0.052186
"PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday - Acadia Healthcare Co  ( NASDAQ:ACHC ) , Boeing  ( NYSE:BA ) ",20221212T133932,https://www.benzinga.com/news/22/12/30040797/paypal-to-rally-around-47-here-are-10-other-price-target-changes-for-monday,BGNE,0.272788,Somewhat-Bullish,0.277959
"The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China",20220311T125204,https://www.benzinga.com/general/biotech/22/03/26098907/the-daily-biotech-pulse-valneva-gains-on-covid-shot-regulatory-update-lucira-health-and-clearside,BGNE,0.146425,Neutral,-0.004485
